Institute for Quantitative Health Science and Engineering at MSU

Name

Institute for Quantitative Health Science and Engineering at MSU

Legal name

Institute for Quantitative Health Science and Engineering at Michigan State University

Website

https://iq.msu.edu

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Biomedical Research Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in Nanotechnology (541713), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Colleges, Universities, and Professional Schools (6113)

SIC

Laboratory Analytical Instruments (3826), Electromedical & Electrotherapeutic Apparatus (3845), Optical Instruments & Lenses (3827)

akta.pro industry

PRIMARYEDAHAEAA

Engineering & Technology Institutes (Comprehensive)

Education/Higher Education (Colleges & Universities)/Technical & Polytechnic Universities

SECONDARYEDAHAEAC

Institutes of Technology (IoT / Technical Universities)

Education/Higher Education (Colleges & Universities)/Technical & Polytechnic Universities

SECONDARYEDAHAEAK

Technical Universities with Computing, Data & AI Focus

Education/Higher Education (Colleges & Universities)/Technical & Polytechnic Universities

Keywords

• Biomedical research institute
• Translational health science
• Stem cell engineering
• Biomedical imaging technology
• Neuroengineering research

Headquarters

HQ city

East Lansing

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations

Marketing channels4 records

Core offering

The Institute for Quantitative Health Science and Engineering (IQ) is a university research institute that conducts fundamental and translational biomedical research across seven interdisciplinary divisions (Biomedical Devices, Biomedical Imaging, Chemical Biology, Developmental and Stem Cell Biology, Neuroengineering, Synthetic Biology, and Systems Biology). It operates advanced core facilities including microscopy, flow cytometry, molecular imaging, genome editing, and 3D printing, and provides graduate and postdoctoral biomedical research training at Michigan State University.

Product overview

The Institute for Quantitative Health Science and Engineering (IQ) at Michigan State University is a university research institute that does not offer commercial products or services. It is organized into seven research divisions (Biomedical Devices, Biomedical Imaging, Chemical Biology, Developmental and Stem Cell Biology, Neuroengineering, Synthetic Biology, and Systems Biology) and operates several core facilities (Advanced Molecular Imaging, Microscopy, Flow Cytometry, Transgenic and Genome Editing, and 3D Printing). The institute conducts fundamental and translational biomedical research, provides graduate education, and supports an entrepreneurship program. All research outputs, technologies, and innovations described are the result of academic research activities rather than commercial product offerings.

Differentiator

Problem solved

Functional benefit

Products and services

• Advanced Molecular Imaging Facility

Quantifiable outcome

• First functioning miniature human heart model developed
• +2 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

13 partnerships are on record, tiered core, major and minor.

• Leica MicrosystemscoreTechnology or Integration · 22 October 2020Partnership established a Center of Excellence on campus in the Bioengineering Building featuring confocal and widefield microscopy technology for cellular and subcellular level imaging with molecular specificity in live and fixed tissue samples. Provides expert technical and applications support in a collaborative environment.
• Corewell HealthcoreStrategic or Co-development Partner$200,000 grant through MSU's alliance with Corewell Health to develop innovative biomimetic dressing for chronic wounds. Focuses on creating oxygen-generating dressings to pioneer groundbreaking approaches for treating hard-to-heal wounds in both veterinary and human medicine.
• JDRFmajorStrategic or Co-development PartnerCollaboration to fight Type 1 diabetes through joint research initiatives leveraging translational research capabilities across veterinary and human medicine.
• Fraunhofer USA Center for Coatings and Diamond TechnologiescoreTechnology or IntegrationPartnership for diamond technology development and application to medical devices. Fraunhofer provides core diamond technology for advanced medical research applications including diamond fiber electrodes for brain monitoring and Parkinson's detection.
• ENIGMA (Enhancing Neuro Imaging Genetics through Meta Analysis)coreStrategic or Co-development PartnerGlobal network of over 2,000 scientists from 45 countries studying health and disease in the human brain. IQ participates through ORIGINs collaboration for infant brain development research with 6,000 participants.
• ORIGINs (Organization for Imaging Genomics in Infancy)coreStrategic or Co-development PartnerMulti-institutional collaboration including scientists from UNC Chapel Hill, UC Irvine, Singapore, Germany, and South Africa. Partners with Knickmeyer's $5.5M NIH study on infant brain development genetics.
• Spectrum Health Helen DeVos Children's HospitalmajorStrategic or Co-development PartnerClinical collaboration with Dr. Joseph Vettukattil for congenital heart disease research. Provides clinical perspective and patient inspiration for Aguirre's heart development studies using organoid models.
• University of WisconsinminorStrategic or Co-development PartnerKip Ludwig from University of Wisconsin serves as co-investigator on $3M NIH grant for diamond electrode brain implants, providing additional expertise in device development.
• University of North Carolina at Chapel HillminorStrategic or Co-development PartnerCollin McKinney and Matthew Verber serve as co-investigators on diamond electrode research project, contributing expertise in neural interface development.
• Washington University in St. LouisminorStrategic or Co-development PartnerChao Zhou, Jinyon Zhou, and Guangming Ni from Washington University collaborated on heart organoid research study.
• University of North Carolina, Chapel HillmajorStrategic or Co-development PartnerCollaborated with MSU on gut microbiome research discovering connection between infant gut bacteria and fear responses. Combined expertise in developmental psychology and microbiome science.
• Stanford UniversitymajorStrategic or Co-development PartnerMultiple collaborations including Nick Leeper on breast cancer Trojan Horse therapy research and Bryan Smith's nanoparticle imaging work with Stanford researchers.
• Johns Hopkins UniversityminorStrategic or Co-development PartnerCollaborated on first-of-its-kind nanoparticle-based in vivo imaging technique for measuring cancer cell mechanics in living animals.

Recent moves7 records

Expansion highlights5 records

Direct peers

• Salk Institute for Biological Studies: Independent biomedical research institute with strengths in stem cell biology, neuroscience, and gene therapy. Highly relevant as IQ Director Aguirre trained at the Salk Institute, and Salk's cardiac regeneration and stem cell work directly maps to IQ's Developmental and Stem Cell Biology Division.
• Wake Forest Institute for Regenerative Medicine: Academic institute specializing in organoid and tissue engineering research, including organ-on-a-chip and regenerative medicine programs. Directly comparable to IQ's heart organoid, biomedical devices, and developmental biology divisions, and similar in its translational vet-to-human focus.
• Allen Institute: Private biomedical research organization running large-scale, team-based programs in brain science and cell science. Relevant peer for IQ's neuroengineering, systems biology, and brain-imaging programs, particularly Knickmeyer's infant brain development genomics work.
• Gladstone Institutes (UCSF): UCSF-affiliated nonprofit research institute running cardiovascular, neuroscience, and regenerative biology programs with strong translational pipelines. Comparable in combining stem cell/organoid research, neurological device work, and biomedical imaging under a single umbrella organization.
• Koch Institute for Integrative Cancer Research at MIT: MIT's cancer-focused research institute that combines bioengineering, nanotechnology, and imaging to drive translational cancer research. Comparable in its use of shared core facilities, nanoparticle drug delivery platforms, and industry co-development models relevant to IQ's Smith lab.
• Wyss Institute for Biologically Inspired Engineering at Harvard: Harvard's translational bioengineering institute that similarly integrates devices, imaging, synthetic biology, and organoid/regenerative medicine under a convergent science model with industry partnerships. Highly comparable mission and operating structure to IQ, though materially larger in scale.
• Morgridge Institute for Research (UW-Madison): Public university-affiliated discovery research institute within the Wisconsin Institutes for Discovery that operates as an interdisciplinary biomedical engineering and regenerative medicine center. Comparable structure, scale, and funding model as a sister institute at another Big Ten public university.

Others

• Leica Microsystems: Microscopy and imaging equipment manufacturer that is IQ's core technology partner through the Center of Excellence designation. Included as an enabling infrastructure partner rather than a research peer, given its supplier role to IQ's Biomedical Imaging division.
• Fraunhofer USA Center for Coatings and Diamond Technologies: Applied research organization that partners with IQ on diamond technology for biomedical devices. Included as a technology/infrastructure partner rather than a research peer, reflecting its enablement of IQ's diamond fiber electrode program.

Broad incumbents

• Broad Institute of MIT and Harvard: Much larger genomics and biomedical research institute that competes for NIH program-level funding and biomedical talent. While its genome-scale orientation is broader than IQ's engineering focus, it represents a primary competitor for federal grants, faculty recruits, and translational partnerships.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/MSUIQ
• Facebookfacebook.com/IQatMSU
• LinkedInlinkedin.com/company/msuiq

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Institute for Quantitative Health Science and Engineering at MSU